White Pine Capital’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

White Pine Capital’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-6,940	Closed	-$589K	–	252
2017 Q4	$589K	Buy	6,940 +25	+0.4%	+$2.09K	0.22%	130
2017 Q3	$599K	Sell	6,915 -410	-6%	-$32.9K	0.23%	123
2017 Q2	$565K	Sell	7,325 -9,825	-57%	-$697K	0.22%	131
2017 Q1	$1.19M	Sell	17,150 -5,400	-24%	-$363K	0.48%	56
2016 Q4	$1.33M	Hold	22,550	–	–	0.57%	45
2016 Q3	$1.5M	Sell	22,550 -700	-3%	-$43.3K	0.64%	39
2016 Q2	$1.26M	Sell	23,250 -300	-1%	-$16.4K	0.53%	47
2016 Q1	$1.22M	Buy	23,550 +4,550	+24%	+$236K	0.52%	51
2015 Q4	$1.33M	Buy	+19,000	New	+$1.3M	0.59%	43

Other funds holding XBI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

White Pine Capital's XBI Position: Q1 2018 in Review

White Pine Capital sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2018, closing a stake of 6,940 shares — an estimated $589K sold.

White Pine Capital first reported a position in XBI in Q4 2015 and held it in 9 quarters. The position peaked at $1.5M in Q3 2016. 414 funds tracked by Wall St. Rank hold XBI as of Q1 2018.

White Pine Capital reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2018 after selling out during the quarter.
White Pine Capital sold 6,940 State Street SPDR S&P Biotech ETF shares in Q1 2018, an estimated $589K.
White Pine Capital first reported a position in State Street SPDR S&P Biotech ETF in Q4 2015 and held it in 9 quarters.
White Pine Capital's State Street SPDR S&P Biotech ETF position peaked at $1.5M in Q3 2016.
414 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2018.

Based on White Pine Capital's 13F filing for Q1 2018, filed 14 May 2018.